Tuberculosis treatment outcomes of non-citizen migrants: Israel compared to other high-income countries

Isr J Health Policy Res. 2020 Aug 3;9(1):29. doi: 10.1186/s13584-020-00386-1.

Abstract

Background: In TB low incidence countries, the outcome of TB treatment among non-citizen migrants from endemic countries affects ability to eliminate TB. This study compares TB treatment outcomes among non-citizen migrants in select pre-elimination country based on their policies for non-citizen migrant TB patients in order to determine how policy affects TB outcomes.

Methods: A literature review was conducted via PUBMED, MEDLINE (2000-2017) on TB policy among non-citizen migrants and treatment outcome. Treatment outcome among migrants diagnosed in Israel during 2000-2014 was analysed.

Results: In total, 18 publications met the inclusion criteria. All the countries reviewed except the United States offered free TB treatment to undocumented migrants. Successful TB treatment outcome for non-citizen migrants in Israel was 87%, the Netherlands was 90.7%, the UK was 82.1%, and outcomes in the US and Australia were not published.

Conclusions: There is a need to standardize results based on international definitions of migrants, asylum seekers, and refugees in order to determine status-specific barriers and to facilitate international comparisons. Policies insuring free access to TB care for non-citizen migrants are an important element for TB elimination in low incidence countries.

Keywords: Comparative study; Migrant health; Tuberculosis.

Publication types

  • Review

MeSH terms

  • Developed Countries
  • Health Policy*
  • Health Services Accessibility / economics
  • Humans
  • Incidence
  • Israel
  • Refugees
  • Transients and Migrants*
  • Treatment Outcome
  • Tuberculosis / epidemiology
  • Tuberculosis / therapy*